Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Pramipexole (Mirapex, Mirapex ER) and Inbrija (levodopa) are both used to treat Parkinson's disease, but they work differently and are used in different ways. Pramipexole is a dopamine agonist taken orally, either as an immediate-release tablet three times a day or as an extended-release tablet once a day. It is available in both brand and generic forms. In contrast, Inbrija is an inhaled medication used to treat "off" episodes in people already taking carbidopa/levodopa medications like Sinemet. It is only available as a brand medication and can be used up to five times a day. Pramipexole can cause side effects like extreme sleepiness, nausea, and dizziness, while Inbrija can cause coughing, changes in saliva color, and nausea. Additionally, Inbrija is not recommended for people with lung conditions like asthma or chronic obstructive pulmonary disease (COPD), whereas pramipexole does not have this restriction.
Pramipexole
Inbrija (levodopa)
Pramipexole
Inbrija (levodopa)
Summary of Mirapex vs. Inbrija
Summary for Dopamine agonist
Prescription only
Pramipexole is used to treat Parkinson's disease (PD) and restless legs syndrome (RLS). The dosage depends on what form you’re taking: the immediate-release tablet is taken 3 times per day and the extended-release tablet is taken once per day. The immediate-release is only available as a lower-cost generic (the brand name Mirapex has been discontinued in the US). The extended-release version of this medication is available as brand (Mirapex ER) and generic. Side effects include nausea, drowsiness, dizziness, and tiredness.
Summary for Anti-Parkinson agent
Prescription only
Inbrija (levodopa) is used to treat "off" episodes (periods when your medications are wearing off so your Parkinson's symptoms come back) in people with Parkinson's disease (PD). It comes as an inhaler that can be used as needed up to 5 times per day, but it can cause cough and darken your spit, saliva, and sweat.
Indications of Mirapex vs. Inbrija
Indications for
•Parkinson's disease
•Moderate-to-severe restless legs syndrome - immediate-release tablets only
Indications for
•Treat "off" episodes in people with Parkinson's disease who are taking medications containing carbidopa and levodopa (e.g., Sinemet, Rytary)
Pros and Cons of Mirapex vs. Inbrija
Pros and Const for Dopamine agonist
Pros
•Works well to control movement problems
•Available in a lower-cost generic version
•Extended-release tablet can be taken once daily
Cons
•Only available as a tablet
•Can cause extreme sleepiness
•Immediate-release tablets need to be taken 3 times per day.
Pros and Const for Anti-Parkinson agent
Pros
•Can be useful for people whose PD medications wear off throughout the day